InnovaDerma PLC Notice of Results, Prospectus and General Meeting (0781T)

TIDMIDP

RNS Number : 0781T

InnovaDerma PLC

22 March 2021

InnovaDerma PLC

("InnovaDerma" or the "Company")

Notice of Results, posting of Prospectus and General Meeting

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, will announce its half year results for the six months ending 31 December 2020 on Wednesday 31 March 2021.

The Company expects to post its Prospectus (which will also comprise an open offer circular) shortly thereafter and hold a General Meeting, with Second Admission (post shareholder approval) occurring in mid April.

The Company will deliver an online presentation on the same day as its results. It is open to all existing and potential investors via the Investor Meet Company platform on Wednesday, 31 March at 9.30am UK time.

Investors can sign up for free via: https://www.investormeetcompany.com/innovaderma-plc/register-investor .

Investors who have already registered and added to meet the Company will be automatically invited.

The presentation is in line with InnovaDerma's commitment to ensuring appropriate communication structures are in place for all sections of its shareholder base so that its strategy, business model and performance are clearly understood.

Questions can be submitted pre-event through the platform or at any time during the live presentation. Management may not be in a position to answer every question it receives but will address those it can while remaining within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.

Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the announcement of the Fundraising made by the Company on 20 January 2021.

Further enquiries

 
 InnovaDerma 
  Blake Hughes                          c/o TB Cardew 
 finnCap Group 
  Geoff Nash/Kate Bannatyne/Edward      [phone] 
  Whiley                                www.finncap.com 
  Alice Lane - Corporate Broking 
                                    ---------------------------- 
 TB Cardew 
  Shan Shan Willenbrock/                + 44 (0)7775 848537 
  Olivia Rosser                         + 44 (0)20 7930 0777 
                                        [e-mail] 
                                    ---------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFLFFSVSIFFIL

(END) Dow Jones Newswires

March 22, 2021 10:25 ET (14:25 GMT)